Tumgik
#strong historic evidence suggests the first and the last hypothesis are both true
lairofsentinel · 3 years
Note
Ok since Mystra came back in 1487, and the game is about 1494, would that mean she immediately went after Gale? Like she was dead until 1487 so... if gale was 20 or younger, 18 when that happened he would be early 30s? I just want to know companions ages...
Ok, this is a long, LONG answer. I've been thinking about this like a month ago, when I was working on my fic. I will show you the different hypotheses I work with, their cons and pros. 
A warning: all this is my personal headcanon and my personal opinion, it doesn't mean it's the “truth”.
[Baldur’s Gate 3 Early Access, Spoilers]
I think you are using some dates a little different or the sources I'm using are wrong.
What we know as canon:
From wiki:
Mystra returned to the Forgotten Realms in 1479 DR. A vestige of Mystra had survived her death in 1385 DR, and was guiding her Chosen to aid in her renewal.
From Forgotten Realm wiki:
In 1479 DR Elminster and Storm restored the Simbul's sanity by feeding her a Blueflame item. After her mind was restored, she charged both Elminster and Manshoon to work to gather all the Blueflame items together, possibly to restore Mystra
Conclusion: Mystra returned in 1479 DR
Another bit of canon: Baldur's Gate 3 takes place in 1492
From Forgotten Realm wiki:
The game takes place as of 1492 DR, and is defined as the "current year", as is stated in a tollhouse ledger. The ledger can be found under the Order of the Gauntlet's makeshift base.
This is one of the “canon” inconsistencies that enrages me, since the game shows it takes place after “the descend to Avernus”, which happens in 1494. Therefore, Larian saying this is placed in 1492 when featuring the ending of the descend to avernus in it, only puts us in a situation with a strong problem in its coherence. I'm just ignoring this by now until Larian corrects themselves. Or  they say something on the matter. So far, I will stick with what the game and its wiki show.   UPDATE: Apparently the one with problems in their date is Descend to Avernus, according wiki: 
 Canon material provides two distinct dates for the events described in Baldur's Gate: Descent into Avernus: the adventure itself, described in chapters 1 through 5, takes place in 1494 DR, according to events mentioned in pages 7 and 47, while the Baldur's Gate Gazetteer describes the city as of 1492 DR (p. 159).
Conclusion: BG3 happens in 1492 DR
Now we are going to proceed to the hypotheses:
Hypothesis one: Gale is around 40 years old.
Reasons: This is my personal headcanon. By the way his face wrinkles, I have the feeling he is closer to his early/middle 40 than his middle 30s. Those crow-feet speak volumes to me. It's true that wrinkles depend a lot of the type of skin you have, your nutrition, your health, your level of stress, and your genetic. There are people who has deep wrinkles in their 20 or a baby-face in their 50s. But statistically speaking, using the average concept of how population gets wrinkles over the years, I'm inclined to think he is in his 40.
If BG3 happens in 1492 DR, and he is 40 y/o, this means he was born in 1452 DR.
Mystra returned from death after 1479, when Gale was 27 years old. This means that Gale's involvement with Mystra happened when he was 27 y/o or older [nothing says that the affair had to happen in that same year, right there after she came back... it could have happened several years later]
Pros: This theory fits a lot more the wrinkles we see with Gale's current age, in my opinion.
Cons: 27 y/o is not “a young man” age in the sense Gale explained during his scene.  Also from a design point of view, and considering the amount of stress and fear that Gale has been living during his last decade [at least], he should be displaying some grey hair as well. First grey hair tends to appear [once again, all this is pure statistical observations in the white population] around their 35's. And it's also well known that constant stress tends to accelerate them, so more evidence against this concept: if he is around 40 y/o and lives stressed as fuck as he has explained, he should be displaying a good amount of grey hair. Maybe we'll see them in a future patch? Maybe not. Only Larian knows.
Hypothesis two: Gale is around 35 [30] years old.
Reasons: This headcanon implies that Gale has more wrinkles than the average of people in such age. But then again, we can't assume this is a rule set on stone. As I said before, skin and genetics depend a lot in the way we age. This age sounds adequate for not displaying grey hair yet, but then again, he is under a lot of stress. It would be expected to have premature grey hair under such conditions.
If BG3 happens in 1492 DR, and he is 35 [30] y/o, this means he was born in 1457 [1462] DR.
Mystra returned from death after 1479, when Gale was 22 [17] years old. This means that Gale's involvement with Mystra happened when he was, at least, 22 [17] y/o or older.
Pros: This theory fits a little less in the amount of  wrinkles we see with Gale's current age in my opinion. It justifies a bit better the lack of grey hair, even though I prefer the idea that, no matter his age, after the orb event, his stress is constant and that should cause premature grey hair. But this is personal taste.
Cons: 22 [17]  y/o is certainly “a young man” age in the sense Gale explained during his scene. I know 17 y/o may sound weird, but we can assume two things: 1) Mystra gave a shit about it [she is a goddess, she cares little for mortal details] or 2) Mystra waited a time before whispering in Gale's ears. Pick the one you prefer. In both cases, 17 and 22, fit perfectly the concept that he was too naïve and young to see the true weight of his involvement with Mystra.
Hypothesis three: Gale is ancient. As a wizard, he can extend his life with magic, artefacts, and potions.
Reasons: This headcanon implies that Gale has lived the Spellplague, and his affair with Mystra happened before 1385 DR and before her death. It could have happened at any age.
In this scenario, since he would be under some magical effect of longevity, we can't even guess his current age, and  his few wrinkles [for an ancient man] and lack of grey hair would be justified by such magical effects as well.
Pro: This theory fits well with whatever inconsistency in his design that could suggest or not certain age in Gale's apperance.
Cons: We are completely lost in the timeline, and we cannot make any decent estimation
I personally do not support this theory because 2 reasons:
When Gale narrates the story of “the little silly wizard”, he explicitly says “not so long ago” when he explained his affair with Mystra. On the other hand, when he explains Karsus' folly, he explicitly says “Long, long time ago”. It's evident in my opinion that he perceives the times of Mystra's death as something that happened too long ago, while placing his own youth in a more recent time frame.
If Gale were ancient, he would speak of the Spellplague time in a more dramatic way. Since Magic and Weave are so important in his life, that historical event should have scarred his mind deeply.
Final conclusion
I personally like the idea of Gale being around his 40. It's true it doesn't fit well when he describes himself as a “young man” during his affair with Mystra, but I think his current design fits more to a man in his early 40. If you read my DOS2 metas, you will also know that Larian is well-known to overlook details of this nature or simply ignore their own lore, so incoherence is something I always expect from them, especially when we do analysis with this freak level of detail.
Gale being 35 y/o or younger is also valid since it's an hypothesis that fits much better the concept of “young man”, though he looks a lot more aged than he should be. One could assume this premature ageing is caused by the stress of the Netherese infection in his chest, but in that case it should be fairer to add to his wrinkles a stronger presence of grey hair.
I don't support at all the theory of Gale being ancient.
101 notes · View notes
vsplusonline · 4 years
Text
No proof smokers protected against COVID-19: epidemiologist explains how studies get misinterpreted
New Post has been published on https://apzweb.com/no-proof-smokers-protected-against-covid-19-epidemiologist-explains-how-studies-get-misinterpreted/
No proof smokers protected against COVID-19: epidemiologist explains how studies get misinterpreted
TORONTO — Can nicotine protect against the novel coronavirus? Are smokers really contracting COVID-19 less often than non-smokers?
If you’ve seen these questions posed in dramatic headlines recently, you might be more than a little perplexed. After all, isn’t smoking a risk factor for COVID-19?
There have been numerous studies related to COVID-19 and smoking released over the past few weeks, and sifting through them all provides a confusing picture of just how a history of smoking affects a COVID-19 patient’s prognosis — or their chances of catching the virus in the first place.
Many studies have shown that when smokers end up in hospital with COVID-19, they have a much higher chance of developing severe complications, or dying.
But at least three recent studies have found a lower percentage of smokers among COVID-19 patients than the percentage of smokers in the general population.
Several news reports have used studies like these to suggest that current smokers may actually be protected from contracting the virus. But is this supported by the science?
In a nutshell, no.
CTVNews.ca talked to Eleanor Murray, an assistant professor of epidemiology at Boston University, to find out when and how these studies are being misinterpreted by media and the general public — and why it’s a concern.
LOW NUMBER OF SMOKERS AMONG COVID-19 PATIENTS?
Two recent studies causing a stir are a Paris study released in late April, and a study conducted in Italy that released a preliminary paper this week.
Both reported low levels of smokers among COVID-19 patients, and both posited this could point to smoking providing some sort of “protection.”
Murray was skeptical of this claim.
Her main issue with the studies she had taken a look at was their limited scope.
“I’m seeing them report just the prevalence of smoking in the COVID patients and the prevalence of smoking in the general population. But for most areas, COVID patients are much older than the general population,” Murray said.
“The life expectancy among smokers is lower than among non-smokers. And so it’s entirely possible that if you’re looking at a sample that’s mostly older individuals, you might just expect any sample like that to have fewer smokers than the overall general population.”
In the Italy study, researchers looked at 441 patients confirmed to have COVID-19 between March 5 and March 31, in Parma, northern Italy.
According to the most recent data from the World Health Organization (WHO), around 23 per cent of Italians over the age of 15 are smokers. But less than five per cent of the COVID-19 patients were active smokers, the study said.
The median age of the patients was 71 years old. And of the 21 Italian smokers in the study who caught the virus, 11 died — a mortality rate significantly higher than for the non-smokers.
The study noted that researchers only looked at symptomatic COVID-19 patients who were receiving treatment, and theorized that “smoking could attenuate the normal defensive function of the immune system, which becomes tolerant of a continuous inflammatory insult, while the immune system of non-smokers may be more prone.”
However, Murray pointed out that a similar theory could be used to explain why the number of smokers among confirmed COVID-19 patients is low.
“If smokers already have decreased lung capacity, they may not notice the milder symptoms of COVID, for example, and they may not [be] getting tested as much,” she said.
The Paris study took a different tack. Comparing 343 inpatients (those being treated in hospital) and 139 outpatients (those being treated at home), they found that only roughly five per cent of each group were daily smokers.
According to WHO, around 31 per cent of those aged 15 and older in France are current smokers, and around 22 per cent are daily smokers.
Roughly 60 per cent of the outpatients and inpatients in the study identified as former smokers, however, leading to another problem: When did they quit?
The duration of a person’s smoking habit is a big confounder in this, Murray said. How long did a former smoker engage in the habit before they quit? How long has a current smoker been smoking regularly?
“It could be, ‘Well, I smoked when [in] my teens, then I quit and now I’m 80 years old and yes, I am a former smoker, but it doesn’t really have anything to do with my life right now,’ versus, ‘Oh, well, I saw on the news there was a respiratory disease going around and so I decided to quit smoking,’” Murray said.
Health officials all over the world have been stressing that smokers should quit in order to minimize their risk of complications if they catch COVID-19.
In the case of the France study, it muddies the data when it’s unclear what percentage of that 60 per cent quit smoking recently.
The France study also specified that they gathered this data by asking patients about their smoking habits, which leaves the possibility that some patients weren’t completely honest.
They acknowledge in the discussion portion of their study that “because this is a cross-sectional study, we cannot confirm the causality of this association,” between smoking and a potential protective effect. They also acknowledged that the outpatients they studied were from a limited area around a Parisian hospital, and that healthcare workers were over-represented in the outpatient group.
Their hypothesis is that it’s not the act of smoking that could protect people, but nicotine itself, theorizing that it could adhere to the cell receptors that the novel coronavirus targets and block the virus.
However, there is no proof of this yet.
The researchers said in April they planned to test further by using nicotine patches on health-care workers in a Paris hospital to measure if the nicotine could protect them, but these additional tests do not appear to have been carried out yet.
“Our findings should be interpreted cautiously,” the initial study said.
These two studies aren’t alone in their findings.
Several other studies assessing smoking and COVID-19 in China and in the U.S. have found lower percentages of smokers among COVID-19 patients than would be expected. But no study has yet revealed a definitive “why,” and Murray pointed out that there are many confounding problems to address, such as the impact of socioeconomic standing on smoking statistics.
“Taking the conclusion from [preliminary studies] that there’s some protective effect of nicotine is probably wishful thinking, just because there’s really no clear evidence here either way of whether smoking is at all protective [against] COVID,” Murray said.
The very idea of smoking being protective against COVID-19 is apparently enticing enough that even when researchers aren’t looking specifically at only smokers, it catches on.
Last week, Murray noticed a specific U.K. study on COVID-19 risk-factors that was gaining traction on Twitter — for all the wrong reasons.
CURRENT SMOKERS DYING OF COVID-19 LESS THAN NON-SMOKERS?
The massive study, released on May 7, was a collaboration between the University of Oxford and the London School of Hygiene and Tropical Medicine. It used anonymized records of 17 million adults in the U.K.’s National Health Service in order to create a list of numerous risk-factors for COVID-19 deaths.
But in the sea of data, what caught the eye of the public were some strange numbers that seemed to imply current smokers were dying of COVID-19 less often than non-smokers.
“The media immediately picked it up and ran with the idea that smoking is protecting people from dying from COVID, [along with other] really strong causal claims, which were not at all the goal of the paper,” Murray said.
“The reason it’s getting play is I think it’s sort of feeding into things that people kind of wanted to be true.”
Murray explained in a “Tweetorial” — a Twitter thread unravelling the miscommunication — that the main issue was finding conclusions where the study only presented observed correlations.
There’s a new paper circulating today about “risk factors” for COVID19 which is getting misinterpreted in a pretty common way: applying conclusions about causation to results obtained via methods designed only for finding correlations.
It’s time for a #tweetorial! pic.twitter.com/8rymWtGW9l
— Ellie Murray (@EpiEllie) May 8, 2020
“There are lots of different goals for research studies and you know, identifying is this a cause of that is not always the goal,” she told CTVNews.ca.
She said this study was simply aiming to describe potential risk factors that researchers might want to look into in the future regarding COVID-19.
In the study, there was a section assessing those who had never smoked, ex-smokers, and current smokers.
When researchers adjusted for only age and sex, current smokers were found to be 25 per cent more likely to die of COVID-19 than non-smokers.
But when researchers adjusted for the other risk factors they were looking at — including heart disease history, weight, lung disease history, etc. — current smokers were actually 14 per cent less likely to die of COVID-19 than non-smokers.
“If you compare smokers and non-smokers who have exactly the same age, level of heart disease, level of cancer history, et cetera, then the smokers seem to be doing better,” Murray said.
This was “one of the big issues,” with the study, she said, particularly when it came to the smoking data.
“An important thing to consider is that if you have heart disease and a history of cancer and you’re a smoker, it’s probably your smoking that has led to a lot of those health problems. But if you’re a non-smoker and you’re getting the same level of cancer history, heart disease, history, et cetera, as a smoker, it’s … quite possible you have a lot of much worse things going on in your life. And so your general health might actually just be less good.”
In other words, smoking is too entangled in some of the other risk factors to adjust for them in this way. We can’t trust the ‘14 per cent less’ figure because of the wider context.
“Adjusting for heart disease will make current smoking look related to COVID hospital death *even if it’s not*!” Murray wrote in her original tweet thread.
If the other cause of heart disease affects COVID19, hospitalization, &/or death in hospital with COVID, we have a problem
Adjusting for heart disease will make current smoking look related to COVID hospital death *even if its not*!
This is “M bias”—a type of collider bias. pic.twitter.com/n2n7qya8TC
— Ellie Murray (@EpiEllie) May 8, 2020
She emphasized that the U.K. study itself was an “impressive effort,” and that the “group should definitely be commended” for their work to compile all of this data.
WHAT HAPPENS WHEN SCIENTIFIC DATA IS TAKEN OUT OF CONTEXT?
“There’s this issue of the media kind of running with [a study’s] findings and over-interpreting them,” Murray said.
She added that when she tweeted out her explanation of the U.K. study, some researchers who had worked on it thanked her for clarifying that they weren’t aiming to imply causation in the smoking data.
It can be dangerous for media and those with large audiences to boost medical theories that haven’t been proven, she said.
“We saw it even a few weeks ago when [U.S.] President Trump was sort of opining on possible medical uses of bleach,” she said. “We saw several cities … in the U.S. reporting [an] uptick in poison control calls after that of people who had ingested bleach.”
“There’s definitely a risk that some people will make decisions which could be harmful for them based on these kinds of information.”
The World Health Organization emphasized this in a May 11 statement on smoking and COVID-19, calling for researchers and media outlets to “be cautious about amplifying unproven claims that tobacco or nicotine could reduce the risk of COVID-19.
“There is currently insufficient information to confirm any link between tobacco or nicotine in the prevention or treatment of COVID-19,” the statement reads.
“Certainly we would not recommend someone to take up smoking based on [these new studies],” Murray said. “And we would still be recommending that people quit smoking because smoking has a lot of negative [health effects].”
“These misinterpretations can be dangerous for the individual and it can be dangerous for other people. It can be dangerous for society as a whole.”
So how can the general public know while reading a study, or a news article about a study, whether it contains advice for their daily life?
“The main thing is to sort of ask yourself, ‘If I was going to make a decision based on this [study], what type of action would I take?’ And then ask yourself whether anyone in the study took that action,” Murray said. “If the study can’t tell you about what happened when people made that decision, you shouldn’t rely on it to make a decision on your own.”
Edited by CTVNews.ca producer Michael Stittle 
Source link
0 notes